关于为心血管植入物开发基于生理学的毒动力学 (PBTK) 模型
Matheos Giakoumi1, Pavlos S Stephanou2, Konstantinos Kapnisis1
1Department of Mechanical Engineering and Materials Science and Engineering, Cyprus University of Technology, Limassol, 3036, Cyprus.
Regulatory toxicology and pharmacology : RTP
|September 2, 2023
概括
这项研究增强了基于生理学的毒性动力学 (PBTK) 模型,以预测医疗设备释放的金属离子. 改进后的模型有助于优化设备设计,并通过评估毒理风险来确保患者的安全.
科学领域:
- 生物医学工程 生物医学工程
- 毒理学 毒理学 毒理学
- 计算生物学 计算生物学
背景情况:
- 医疗器械中的金属离子漏会给健康带来风险.
- 监管机构要求对医疗器械制定严格的质量和安全标准.
- 推对医疗器械提交进行建模和模拟.
研究的目的:
- 增强一个基于生理学的毒性动力学 (PBTK) 模型,用于预测医疗器械的金属离子释放.
- 为了整合改进的生理表征和时间依赖的生物动力学参数.
- 为优化设备设计和毒理风险评估提供计算工具.
主要方法:
- 一个PBTK模型的扩展,增加了一个额外的组织区和时间依赖的功能.
- 应用概率学,蒙特卡洛方法论的置信区间和可变性分析.
- 模型预测与含心血管器械的人类和迷你猪数据的验证.
主要成果:
- 改进的PBTK模型准确预测金属离子生物分布.
- 模型验证证实了与体内数据的定量一致性.
- 开发了一种用于区间毒理风险评估的新方法.
结论:
- 增强的PBTK模型作为医疗器械开发的有价值的计算工具.
- 该模型有助于防止过度释放物质,并确保患者的安全.
- 这种方法支持监管合规,并优化设备性能.
相关概念视频
Pharmacokinetic Models: Overview
776
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
776
Pharmacokinetic Models: Comparison and Selection Criterion
104
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
104
Model Approaches for Pharmacokinetic Data: Physiological Models
73
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
73
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
61
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
61
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
115
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
115
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
96
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
96


